The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Osteopontin—a molecule for all seasons
Abstract
Osteopontin (OPN) is a multifunctional protein, and although highly expressed in bone, it is also expressed by various cell types including macrophages, endothelial cells, smooth muscle cells and epithelial cells.1,2 OPN is involved in diverse biological processes and the aim of this review is to give a broad outline of some important aspects of the biology of OPN. Although this review is written primarily from a renal perspective, it is hoped that the reader will appreciate that OPN is involved in both physiological and pathological processes in multiple organs and tissues including biomineralization, inflammation, leukocyte recruitment and cell survival. OPN is a negatively‐charged acidic hydrophilic protein of approximately 300 amino acid residues, and is secreted into all body fluids. The OPN cDNA from various mammalian species exhibits a high degree of sequence homology. There is evidence of alternative splicing, although the functional significance of this is unclear at present. The molecule undergoes considerable post‐translational modification, and is phosphorylated and glycosylated. OPN has an arginine‐glycine‐aspartic acid (RGD) cell binding sequence, a calcium binding site and two heparin binding domains. Cells may bind OPN via multiple integrin receptors including the vitronectin receptor (αvβ3) as well as various β1 and β5 integrins. Integrin binding may be RGD‐dependent or ‐independent (e.g. via the motif SVVYGLR). OPN does not bind the standard form of CD44 (hyaluronic acid receptor) but does bind various isoforms of CD44. These CD44 isoforms bind OPN via multiple sites. OPN may be cleaved by thrombin, resulting in the exposure of additional cryptic binding sites as well as the production of functional chemotactic fragments.3 The regulation of OPN expression is incompletely understood at present and may differ between various cell types. Studies indicate that the OPN promoter contains various motifs including a purine‐rich sequence, an ets‐like sequence, glucocorticoid and vitamin D response elements and interferon‐inducible elements.4–6 Pro‐inflammatory cytokines stimulate OPN gene transcription and expression. For example, activation of macrophages with lipopolysaccharide (LPS) and nitric oxide (NO) induces OPN gene expression and protein secretion.7 Classical mediators of acute inflammation such as tumour necrosis factor α (TNFα) and interleukin‐1β (IL‐1β) strongly induce OPN expression4,5,8 while other mediators that can induce OPN upregulation include angiotensin II, transforming growth factor β(TGFβ), hyperglycaemia and hypoxia.9–14 OPN is intimately involved in the regulation of both physiological and pathological mineralization. In normal bone tissue, OPN is expressed by both osteoclasts and osteoblasts which are the cells responsible for bone remodelling. During normal bone mineralization, osteoclast‐derived OPN inhibits the formation of hydroxyapatite.15,16 Despite the fact that OPN knockout mice exhibit a normal bone structure,17 there is evidence indicating that OPN is involved in bone resorption. For example, OPN knockout mice are markedly protected from bone loss following ovariectomy.18 In addition, bone resorption mediated by parathyroid hormone is also OPN‐dependent.19 Prominent OPN expression is found in regions of dystrophic calcification such as that associated with degenerative and atheromatous vascular disease.20–24 Experiments using an in vitro model of smooth muscle cell calcification indicate that OPN exerts an inhibitory effect upon this process,25 thereby suggesting that the upregulation of OPN evident in areas of dystrophic calcification represents an attempt to either prevent or limit vascular calcification. OPN is also an important facet of the urinary tract's defence against the formation of renal stones, the majority of which are comprised of calcium oxalate. As a consequence of the essential homeostatic conservation of water, normal urine is supersaturated with respect to crystalline components, and this empirically suggests the existence of physiological mechanisms that actively inhibit urinary crystallization of calcium salts. Various inhibitory macromolecules including urinary OPN have now been isolated and identified from both normal urine and kidney stones, e.g. nephrocalcin, crystal matrix protein, bikunin and Tamm‐Horsfall protein.26–30 OPN is synthesized within the kidney and secreted into the urine by epithelial cells, including the loop of Henle, distal convoluted tubule and papillary epithelium.31,32 OPN can inhibit the nucleation, growth and aggregation of calcium oxalate crystals in vitro26,33 and directly inhibits the binding of calcium oxalate crystals to cultured renal epithelial cells.34 In addition, OPN directs calcium oxalate crystallization to the calcium oxalate dihydrate phase, which is significantly less adherent to renal tubular epithelial cells than the calcium oxalate monohydrate phase.35,36 Are the inhibitory properties of OPN regard
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Eta-1 (Osteopontin): An Early Component of Type-1 (Cell-Mediated) Immunity
Ashkar, S., Weber, G. F., Panoutsakopoulou, V., Sanchirico, M. E., Jansson, M., Zawaideh, S., Rittling, S. R., Denhardt, D. T., Glimcher, M. J., & Cantor, H. (2000) · Science · doi:10.1126/science.287.5454.860 · Cited by 1,125
Osteopontin: a protein with diverse functions
Denhardt, D. T., & Guo, X. (1993) · The FASEB Journal · doi:10.1096/fasebj.7.15.8262332 · Cited by 1,078
Altered wound healing in mice lacking a functional osteopontin gene (spp1).
Liaw, L., Birk, D. E., Ballas, C. B., Whitsitt, J. S., Davidson, J. M., & Hogan, B. L. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2131 · Cited by 663
Nucleation and inhibition of hydroxyapatite formation by mineralized tissue proteins
HUNTER, G. K., HAUSCHKA, P. V., POOLE, R. A., ROSENBERG, L. C., & GOLDBERG, H. A. (1996) · Biochemical Journal · doi:10.1042/bj3170059 · Cited by 621
High expression of genes for calcification-regulating proteins in human atherosclerotic plaques.
Shanahan, C. M., Cary, N. R., Metcalfe, J. C., & Weissberg, P. L. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117246 · Cited by 611
NF-κB Mediates αvβ3 Integrin-induced Endothelial Cell Survival
Scatena, M., Almeida, M., Chaisson, M. L., Fausto, N., Nicosia, R. F., & Giachelli, C. M. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.141.4.1083 · Cited by 485
Calcification of Vascular Smooth Muscle Cell Cultures: Inhibition by Osteopontin
Wada, T., McKee, M. D., Steitz, S., & Giachelli, C. M. (1999) · Circulation Research · doi:10.1161/01.res.84.2.166 · Cited by 458
Osteopontin Is Expressed in Human Aortic Valvular Lesions
O’Brien, K. D., Kuusisto, J., Reichenbach, D. D., Ferguson, M., Giachelli, C., Alpers, C. E., & Otto, C. M. (1995) · Circulation · doi:10.1161/01.cir.92.8.2163 · Cited by 440
Rittling, S. R., Matsumoto, H. N., Mckee, M. D., Nanci, A., An, X.-R., Novick, K. E., Kowalski, A. J., Noda, M., & Denhardt, D. T. (1998) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1998.13.7.1101 · Cited by 438
Hunter, G. K., Kyle, C. L., & Goldberg, H. A. (1994) · Biochemical Journal · doi:10.1042/bj3000723 · Cited by 432
Cited by
Nilsson, S. K., Johnston, H. M., Whitty, G. A., Williams, B., Webb, R. J., Denhardt, D. T., Bertoncello, I., Bendall, L. J., Simmons, P. J., & Haylock, D. N. (2005) · Blood · doi:10.1182/blood-2004-11-4422 · Cited by 806
Huh, C.-G., Factor, V. M., Sánchez, A., Uchida, K., Conner, E. A., & Thorgeirsson, S. S. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0306068101 · Cited by 750
The multiple functions and mechanisms of osteopontin
Icer, M. A., & Gezmen-Karadag, M. (2018) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2018.07.003 · Cited by 606
Nilsson, E., Jansson, P. A., Perfilyev, A., Volkov, P., Pedersen, M., Svensson, M. K., Poulsen, P., Ribel-Madsen, R., Pedersen, N. L., Almgren, P., et al. (2014) · Diabetes · doi:10.2337/db13-1459 · Cited by 391
Glial response during cuprizone-induced de- and remyelination in the CNS: lessons learned
Gudi, V., Gingele, S., Skripuletz, T., & Stangel, M. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00073 · Cited by 375
Metadata
- Authors
- Mazzali, M., Kipari, T., Ophascharoensuk, V., Wesson, J. A., Johnson, R., & Hughes, J.
- Venue
- QJM: An International Journal of Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2002-01
- Volume
- 95
- Issue
- 1
- Pages
- 3-13
- ISSN
- 0033-5622 (ISSN-L)
- 1460-2393
- 1460-2725
- OpenAlex
- W2160570558
- Cited by
- 392
- References
- 66
- FWCI
- 7.80
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Osteopontin—a molecule for all seasons. https://app.cochat.ai/papers/10.1093/qjmed/95.1.3
- The paper
- Mazzali, M., Kipari, T., Ophascharoensuk, V., Wesson, J. A., Johnson, R., & Hughes, J. (2002). Osteopontin—a molecule for all seasons. QJM: An International Journal of Medicine. https://doi.org/10.1093/qjmed/95.1.3
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.